2,3-dioxo-1,2,3,4-tetrahydro-6-quinoxalinecarboxylic acid hydrate, 95.0%, 10g

(S)-3,5-dichloro-N-((1-ethylpyrrolidin-2-yl)methyl)-2,6-dihydroxybenzamide, 98%, 250mg

8-Chloroimidazo[1,2-a]pyridine-2-carbaldehyde, 97%, 1g

3-(2-methoxyphenyl)-4-(4-methylphenyl)-4,5-dihydro-1H-1,2,4-triazole-5-thione, 95+%, 250mg

n-(But-3-yn-1-yl)oxetan-3-amine, 98%, 500mg

(2R)-1-BOC-2-PROPYLPYRROLIDINE-2-METHANAMINE, 95.0%, 250mg

(2-Butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone, 95.0%, 25g

2-(3-(But-3-yn-1-yl)-3H-diazirin-3-yl)acetic acid, 95%, 250mg

2-Ethoxy-4-fluorobenzotrifluoride, 97%, 100mg

Syringe filters ROTILABO® PVDF, 0,45 µm, 13 mm, 100 Piece(s)

2,5-Dimethyl-3-hexyne-2,5-diol>99.0%(GC)500g

(2-Aminophenyl)diethylphosphine oxide, 98%, 100mg

2,6-Difluoro-4-iodobenzotrifluoride, 1g